Laboratory of Neurogenomiks
University of Queensland
Brisbane, AustraliaPublikationen in Zusammenarbeit mit Forschern von University of Queensland (3)
2020
-
NLRP3 inflammasome as prognostic factor and therapeutic target in primary progressive multiple sclerosis patients
Brain : a journal of neurology, Vol. 143, Núm. 5, pp. 1414-1430
2015
-
A rare P2X7 variant Arg307Gln with absent pore formation function protects against neuroinflammation in multiple sclerosis
Human Molecular Genetics, Vol. 24, Núm. 19, pp. 5644-5654
2012
-
Closing the case of APOE in multiple sclerosis: No association with disease risk in over 29 000 subjects
Journal of Medical Genetics, Vol. 49, Núm. 9, pp. 558-562